Chemoinformaics analysis of 1-(Dimethoxymethyl)-4-methoxybenzene
Molecular Weight | 182.219 | nRot | 4 |
Heavy Atom Molecular Weight | 168.107 | nRig | 6 |
Exact Molecular Weight | 182.094 | nRing | 1 |
Solubility: LogS | -1.648 | nHRing | 0 |
Solubility: LogP | 1.601 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 28.4411 |
nHD | 0 | BPOL | 19.2529 |
QED | 0.666 |
Synth | 1.937 |
Natural Product Likeliness | -0.131 |
NR-PPAR-gamma | 0.001 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.021 |
Pgp-sub | 0.038 |
HIA | 0.003 |
CACO-2 | -4.231 |
MDCK | 0.0000364 |
BBB | 0.847 |
PPB | 0.55083 |
VDSS | 1.448 |
FU | 0.299268 |
CYP1A2-inh | 0.055 |
CYP1A2-sub | 0.748 |
CYP2c19-inh | 0.148 |
CYP2c19-sub | 0.856 |
CYP2c9-inh | 0.027 |
CYP2c9-sub | 0.327 |
CYP2d6-inh | 0.046 |
CYP2d6-sub | 0.877 |
CYP3a4-inh | 0.036 |
CYP3a4-sub | 0.498 |
CL | 7.421 |
T12 | 0.226 |
hERG | 0.024 |
Ames | 0.128 |
ROA | 0.036 |
SkinSen | 0.314 |
Carcinogencity | 0.558 |
EI | 0.992 |
Respiratory | 0.027 |
NR-Aromatase | 0.009 |
Antiviral | No |
Prediction | 0.873919 |